QLGN
Qualigen Therapeutics Inc
Halal Rating :
Last Price
$4.04
Last updated:
Market Cap
-
7D Change
-1.46%
1 Year Change
719.47%
Company Overview
Industries
Exchange
Next Earnings Date
Qualigen Therapeutics Inc is a biotechnology company focused on developing novel therapeutic products for the treatment of cancer and infectious diseases. The company is primarily engaged in research and development activities, with its lead therapeutic candidates including QN-302 for the treatment of pancreatic cancer.
Use of Interest
| Reporting Date | Total Revenue | Total Operating Expense | Interest Income | Interest Expense | Interest Income Ratio | Interest Expense Ratio |
|---|
Company Impact
Help us evaluate Qualigen Therapeutics Inc's impact from a halal perspective. Vote on the most significant aspect and submit any considerations that we may have missed.